Thomas Klimkait
Assessing efficacy of different nucleos(t)ide backbones in NNRTI-containing regimens in the Swiss HIV Cohort Study
Yang W, Swiss HIV Cohort Study (SHCS), Günthard H, Ledergerber B, Held L, Vernazza P, Bernasconi E, Cavassini M, Battegay M, Hirzel C, Aubert V, Klimkait T, Yerly S, Shah C, Böni J, Scherrer A, Kouyos R, Swiss HIV Cohort Study SHCS. Assessing efficacy of different nucleos(t)ide backbones in NNRTI-containing regimens in the Swiss HIV Cohort Study. J Antimicrob Chemother 2015
Sep 11, 2015Assessing efficacy of different nucleos(t)ide backbones in NNRTI-containing regimens in the Swiss HIV Cohort Study
Sep 11, 2015J Antimicrob Chemother 2015
Yang Wan-Lin, Swiss HIV Cohort Study (SHCS), Günthard Huldrych F, Ledergerber Bruno, Held Leonhard, Vernazza Pietro, Bernasconi Enos, Cavassini Matthias, Battegay Manuel, Hirzel Cédric, Aubert Vincent, Klimkait Thomas, Yerly Sabine, Shah Cyril, Böni Jürg, Scherrer Alexandra U, Kouyos Roger D, Swiss HIV Cohort Study SHCS
Syphilis: Diagnostik und Behandlung
Itin P, Schmid P, Bernasconi E, Harry D, Boffi El Amari E, Herold M, Klimkait T, Kahlert C, Furrer H, Lautenschlager S, Calmy A, Cavassini M, Oertle D, Low N, Bosshard P, Toutous-Trellu L, Schmidt A, Vernazza P, Tarr P, Stoeckle M, Wymann M, Ciardo D, Class J, Scheidegger C, Fehr J. Syphilis: Diagnostik und Behandlung - Aktualisierte Empfehlungen der Eidgenössischen Kommission für Sexuelle Gesundheit. Schweizerisches Medizin-Forum 2015; 15:459-465.
May 6, 2015Syphilis: Diagnostik und Behandlung
May 6, 2015Schweizerisches Medizin-Forum 2015; 15:459-465
Itin Peter, Schmid Patrick, Bernasconi Enos, Harry David, Boffi El Amari Emnanuelle, Herold Markus, Klimkait Thomas, Kahlert Christian, Furrer Hansjakob, Lautenschlager Stephan, Calmy Alexandra, Cavassini Matthias, Oertle Daniel, Low Nicola, Bosshard Philipp P., Toutous-Trellu Laurence, Schmidt Axel J., Vernazza Pietro, Tarr Philip, Stoeckle Marcel, Wymann Monica, Ciardo Diana, Class Johanna, Scheidegger Claude, Fehr Jan
Assessing the Paradox Between Transmitted and Acquired HIV Type 1 Drug Resistance Mutations in the Swiss HIV Cohort Study From 1998 to 2012
Yang W, Günthard H, Ledergerber B, Held L, Vernazza P, Bernasconi E, Cavassini M, Battegay M, Furrer H, Aubert V, Klimkait T, Yerly S, Shah C, Böni J, Scherrer A, Kouyos R, Swiss HIV Cohort Study. Assessing the Paradox Between Transmitted and Acquired HIV Type 1 Drug Resistance Mutations in the Swiss HIV Cohort Study From 1998 to 2012. J Infect Dis 2015
Jan 9, 2015Assessing the Paradox Between Transmitted and Acquired HIV Type 1 Drug Resistance Mutations in the Swiss HIV Cohort Study From 1998 to 2012
Jan 9, 2015J Infect Dis 2015
Yang Wan-Lin, Günthard Huldrych F, Ledergerber Bruno, Held Leonhard, Vernazza Pietro, Bernasconi Enos, Cavassini Matthias, Battegay Manuel, Furrer Hansjakob, Aubert Vincent, Klimkait Thomas, Yerly Sabine, Shah Cyril, Böni Jürg, Scherrer Alexandra U, Kouyos Roger, Swiss HIV Cohort Study
Generation of a Recombinant Gag Virus-Like-Particle Panel for the Evaluation of p24 Antigen Detection by Diagnostic HIV Tests
Vetter B, Böni J, Shah C, Yerly S, Suter-Riniker F, Schottstedt V, Schmid P, Regenass S, Klimkait T, Dollenmaier G, Ciardo D, Brandenberger M, Aubert V, Niederhauser C, Fransen K, Orlowski V, Schüpbach J. Generation of a Recombinant Gag Virus-Like-Particle Panel for the Evaluation of p24 Antigen Detection by Diagnostic HIV Tests. PloS one 2014; 9:e111552.
Oct 24, 2014Generation of a Recombinant Gag Virus-Like-Particle Panel for the Evaluation of p24 Antigen Detection by Diagnostic HIV Tests
Oct 24, 2014PloS one 2014; 9:e111552
Vetter Beatrice N, Böni Jürg, Shah Cyril, Yerly Sabine, Suter-Riniker Franziska, Schottstedt Volkmar, Schmid Patrick, Regenass Stephan, Klimkait Thomas, Dollenmaier Günter, Ciardo Diana, Brandenberger Marcel, Aubert Vincent, Niederhauser Christoph, Fransen Katrien, Orlowski Vanessa, Schüpbach Jörg
Limited clinical benefit of minority K103N and Y181C-variant detection in addition to routine genotypic resistance testing in antiretroviral therapy-naive patients
Metzner K, Günthard H, Weber R, Bernasconi E, Calmy A, Cavassini M, Vernazza P, Hirsch H, Furrer H, Aubert V, Klimkait T, Yerly S, Böni J, von Wyl V, Scherrer A, the Swiss HIV Cohort Study. Limited clinical benefit of minority K103N and Y181C-variant detection in addition to routine genotypic resistance testing in antiretroviral therapy-naive patients. AIDS 2014; 28:2231-2239.
Sep 24, 2014Limited clinical benefit of minority K103N and Y181C-variant detection in addition to routine genotypic resistance testing in antiretroviral therapy-naive patients
Sep 24, 2014AIDS 2014; 28:2231-2239
Metzner Karin J, Günthard Huldrych F, Weber Rainer, Bernasconi Enos, Calmy Alexandra, Cavassini Matthias, Vernazza Pietro, Hirsch Hans H, Furrer Hansjakob, Aubert Vincent, Klimkait Thomas, Yerly Sabine, Böni Jürg, von Wyl Viktor, Scherrer Alexandra U, the Swiss HIV Cohort Study
Higher Risk of Incident Hepatitis C Virus Coinfection Among Men Who Have Sex With Men, in Whom the HIV Genetic Bottleneck at Transmission Was Wide
Kouyos R, Ledergerber B, Bernasconi E, Vernazza P, Battegay M, Cavassini M, Calmy A, Kovari H, Shah C, Aubert V, Klimkait T, Yerly S, Böni J, Yang W, Braun D, Rauch A, Günthard H. Higher Risk of Incident Hepatitis C Virus Coinfection Among Men Who Have Sex With Men, in Whom the HIV Genetic Bottleneck at Transmission Was Wide. J Infect Dis 2014; 210:1555-61.
Jun 18, 2014Higher Risk of Incident Hepatitis C Virus Coinfection Among Men Who Have Sex With Men, in Whom the HIV Genetic Bottleneck at Transmission Was Wide
Jun 18, 2014J Infect Dis 2014; 210:1555-61
Kouyos Roger D, Ledergerber Bruno, Bernasconi Enos, Vernazza Pietro, Battegay Manuel, Cavassini Matthias, Calmy Alexandra, Kovari Helen, Shah Cyril, Aubert Vincent, Klimkait Thomas, Yerly Sabine, Böni Jürg, Yang Wan-Lin, Braun Dominique L, Rauch Andri, Günthard Huldrych F
Clustering of HCV coinfections on HIV phylogeny indicates domestic and sexual transmission of HCV
Kouyos R, Günthard H, Ledergerber B, Bernasconi E, Vernazza P, Battegay M, Cavassini M, Calmy A, Kovari H, Klimkait T, Aubert V, Shah C, Yerly S, Böni J, Rauch A, Swiss HIV Cohort Study (SHCS). Clustering of HCV coinfections on HIV phylogeny indicates domestic and sexual transmission of HCV. Int J Epidemiol 2014; 43:887-96.
Jan 22, 2014Clustering of HCV coinfections on HIV phylogeny indicates domestic and sexual transmission of HCV
Jan 22, 2014Int J Epidemiol 2014; 43:887-96
Kouyos Roger D, Günthard Huldrych F, Ledergerber Bruno, Bernasconi Enos, Vernazza Pietro, Battegay Manuel, Cavassini Matthias, Calmy Alexandra, Kovari Helen, Klimkait Thomas, Aubert Vincent, Shah Cyril, Yerly Sabine, Böni Jürg, Rauch Andri, Swiss HIV Cohort Study (SHCS)
A genome-to-genome analysis of associations between human genetic variation, HIV-1 sequence diversity, and viral control
Bartha I, Yerly S, O'Brien S, Listgarten J, Pfeifer N, Lippert C, Fusi N, Kutalik Z, Allen T, Müller V, Harrigan P, Heckerman D, Telenti A, Klimkait T, Vernazza P, Bernasconi E, Carlson J, Brumme C, McLaren P, Brumme Z, John M, Haas D, Martinez-Picado J, Dalmau J, López-Galíndez C, Casado C, Rauch A, Günthard H, Fellay J. A genome-to-genome analysis of associations between human genetic variation, HIV-1 sequence diversity, and viral control. Elife 2013; 2:e01123.
Oct 29, 2013A genome-to-genome analysis of associations between human genetic variation, HIV-1 sequence diversity, and viral control
Oct 29, 2013Elife 2013; 2:e01123
Bartha István, Yerly Sabine, O'Brien Stephen J, Listgarten Jennifer, Pfeifer Nico, Lippert Christoph, Fusi Nicolo, Kutalik Zoltán, Allen Todd M, Müller Viktor, Harrigan P Richard, Heckerman David, Telenti Amalio, Klimkait Thomas, Vernazza Pietro, Bernasconi Enos, Carlson Jonathan M, Brumme Chanson J, McLaren Paul J, Brumme Zabrina L, John Mina, Haas David W, Martinez-Picado Javier, Dalmau Judith, López-Galíndez Cecilio, Casado Concepción, Rauch Andri, Günthard Huldrych F, Fellay Jacques
Treatment-naive individuals are the major source of transmitted HIV-1 drug resistance in men who have sex with men in the Swiss HIV Cohort Study
Drescher S, Kouyos R, Günthard H, Ledergerber B, Vernazza P, Bernasconi E, Cavassini M, Ambrosioni J, Battegay M, Furrer H, Taffé P, Klimkait T, Aubert V, Shah C, Yerly S, Böni J, Yang W, von Wyl V, Swiss HIV Cohort Study. Treatment-naive individuals are the major source of transmitted HIV-1 drug resistance in men who have sex with men in the Swiss HIV Cohort Study. Clin Infect Dis 2013; 58:285-94.
Oct 21, 2013Treatment-naive individuals are the major source of transmitted HIV-1 drug resistance in men who have sex with men in the Swiss HIV Cohort Study
Oct 21, 2013Clin Infect Dis 2013; 58:285-94
Drescher Sara M, Kouyos Roger D, Günthard Huldrych F, Ledergerber Bruno, Vernazza Pietro, Bernasconi Enos, Cavassini Matthias, Ambrosioni Juan, Battegay Manuel, Furrer Hansjakob, Taffé Patrick, Klimkait Thomas, Aubert Vincent, Shah Cyril, Yerly Sabine, Böni Jürg, Yang Wan-Lin, von Wyl Viktor, Swiss HIV Cohort Study
Adherence as a predictor of the development of class-specific resistance mutations: the Swiss HIV Cohort Study
von Wyl V, Glass T, Bucher H, Günthard H, Aubert V, Böni J, Bernasconi E, Calmy A, Cavassini M, Furrer H, Nicca D, Yerly S, Klimkait T, Swiss HIV Cohort Study. Adherence as a predictor of the development of class-specific resistance mutations: the Swiss HIV Cohort Study. PloS one 2013; 8:e77691.
Oct 16, 2013Adherence as a predictor of the development of class-specific resistance mutations: the Swiss HIV Cohort Study
Oct 16, 2013PloS one 2013; 8:e77691
von Wyl Viktor, Glass Tracy R, Bucher Heiner C, Günthard Huldrych F, Aubert Vincent, Böni Jürg, Bernasconi Enos, Calmy Alexandra, Cavassini Matthias, Furrer Hansjakob, Nicca Dunja, Yerly Sabine, Klimkait Thomas, Swiss HIV Cohort Study
The individualized genetic barrier predicts treatment response in a large cohort of HIV-1 infected patients
Beerenwinkel N, Günthard H, Cellerai C, Klimkait T, Böni J, Yerly S, Bernasconi E, Vernazza P, Cavassini M, Hirschel B, Battegay M, Furrer H, von Wyl V, Knupfer P, Schuhmacher H, Montazeri H, Swiss HIV Cohort Study. The individualized genetic barrier predicts treatment response in a large cohort of HIV-1 infected patients. PLoS Comput Biol 2013; 9:e1003203.
Aug 29, 2013The individualized genetic barrier predicts treatment response in a large cohort of HIV-1 infected patients
Aug 29, 2013PLoS Comput Biol 2013; 9:e1003203
Beerenwinkel Niko, Günthard Huldrych F, Cellerai Cristina, Klimkait Thomas, Böni Jürg, Yerly Sabine, Bernasconi Enos, Vernazza Pietro, Cavassini Matthias, Hirschel Bernard, Battegay Manuel, Furrer Hansjakob, von Wyl Viktor, Knupfer Patrick, Schuhmacher Heike, Montazeri Hesam, Swiss HIV Cohort Study
Correction: Long-Lasting Protection of Activity of Nucleoside Reverse Transcriptase Inhibitors and Protease Inhibitors (PIs) by Boosted PI Containing Regimens
Scherrer A, Günthard H, Ledergerber B, Bernasconi E, Vernazza P, Elzi L, Cavassini M, Calmy A, Furrer H, Aubert V, Klimkait T, Yerly S, Böni J, the Swiss HIV Cohort Study (SHCS). Correction: Long-Lasting Protection of Activity of Nucleoside Reverse Transcriptase Inhibitors and Protease Inhibitors (PIs) by Boosted PI Containing Regimens. PloS one 2013; 8
Jul 25, 2013Correction: Long-Lasting Protection of Activity of Nucleoside Reverse Transcriptase Inhibitors and Protease Inhibitors (PIs) by Boosted PI Containing Regimens
Jul 25, 2013PloS one 2013; 8
Scherrer Alexandra U, Günthard Huldrych F, Ledergerber Bruno, Bernasconi Enos, Vernazza Pietro, Elzi Luigia, Cavassini Matthias, Calmy Alexandra, Furrer Hansjakob, Aubert Vincent, Klimkait Thomas, Yerly Sabine, Böni Jürg, the Swiss HIV Cohort Study (SHCS)
Origin of minority drug-resistant HIV-1 variants in primary HIV-1 infection
Metzner K, Aubert V, Furrer H, Battegay M, Vernazza P, Cavassini M, Calmy A, Bernasconi E, Weber R, Günthard H, Klimkait T, Yerly S, Böni J, Scherrer A, Preiswerk B, Joos B, von Wyl V, Leemann C, Rieder P, Braun D, Grube C, Kuster H, Swiss HIV Cohort Study. Origin of minority drug-resistant HIV-1 variants in primary HIV-1 infection. J Infect Dis 2013; 208:1102-12.
Jul 11, 2013Origin of minority drug-resistant HIV-1 variants in primary HIV-1 infection
Jul 11, 2013J Infect Dis 2013; 208:1102-12
Metzner Karin J, Aubert Vincent, Furrer Hansjakob, Battegay Manuel, Vernazza Pietro, Cavassini Matthias, Calmy Alexandra, Bernasconi Enos, Weber Rainer, Günthard Huldrych F, Klimkait Thomas, Yerly Sabine, Böni Jürg, Scherrer Alexandra U, Preiswerk Benjamin, Joos Beda, von Wyl Viktor, Leemann Christine, Rieder Philip, Braun Dominique, Grube Christina, Kuster Herbert, Swiss HIV Cohort Study
Higher CNS penetration-effectiveness of long-term combination antiretroviral therapy is associated with better HIV-1 viral suppression in cerebrospinal fluid
Cusini A, Günthard H, Opravil M, Gutmann C, Zenger F, Klimkait T, Cavassini M, Gaudenz R, Hirschel B, Widmer N, Rohrbach J, Fux C, Ledergerber B, Decosterd L, Yerly S, Vernazza P, Swiss HIV Cohort Study. Higher CNS penetration-effectiveness of long-term combination antiretroviral therapy is associated with better HIV-1 viral suppression in cerebrospinal fluid. J Acquir Immune Defic Syndr 2013; 62:28-35.
Jan 1, 2013Higher CNS penetration-effectiveness of long-term combination antiretroviral therapy is associated with better HIV-1 viral suppression in cerebrospinal fluid
Jan 1, 2013J Acquir Immune Defic Syndr 2013; 62:28-35
Cusini Alexia, Günthard Huldyrich F, Opravil Milos, Gutmann Christine, Zenger Franziska, Klimkait Thomas, Cavassini Matthias, Gaudenz Roman, Hirschel Bernhard, Widmer Nicolas, Rohrbach Janine, Fux Christoph A, Ledergerber Bruno, Decosterd Laurent A, Yerly Sabine, Vernazza Pietro, Swiss HIV Cohort Study
Long-lasting protection of activity of nucleoside reverse transcriptase inhibitors and protease inhibitors (PIs) by boosted PI containing regimens
Scherrer A, Günthard H, Ledergerber B, Bernasconi E, Vernazza P, Elzi L, Cavassini M, Calmy A, Furrer H, Aubert V, Klimkait T, Yerly S, Böni J, Swiss HIV Cohort Study (SHCS). Long-lasting protection of activity of nucleoside reverse transcriptase inhibitors and protease inhibitors (PIs) by boosted PI containing regimens. PloS one 2012; 7:e50307.
Nov 26, 2012Long-lasting protection of activity of nucleoside reverse transcriptase inhibitors and protease inhibitors (PIs) by boosted PI containing regimens
Nov 26, 2012PloS one 2012; 7:e50307
Scherrer Alexandra U, Günthard Huldrych F, Ledergerber Bruno, Bernasconi Enos, Vernazza Pietro, Elzi Luigia, Cavassini Matthias, Calmy Alexandra, Furrer Hansjakob, Aubert Vincent, Klimkait Thomas, Yerly Sabine, Böni Jürg, Swiss HIV Cohort Study (SHCS)
Minor protease inhibitor mutations at baseline do not increase the risk for a virological failure in HIV-1 subtype B infected patients
Scherrer A, Günthard H, Bernasconi E, Vernazza P, Elzi L, Cavassini M, Calmy A, Furrer H, Cellerai C, Klimkait T, Yerly S, Böni J, von Wyl V, Ledergerber B, Swiss HIV Cohort Study. Minor protease inhibitor mutations at baseline do not increase the risk for a virological failure in HIV-1 subtype B infected patients. PloS one 2012; 7:e37983.
Jun 18, 2012Minor protease inhibitor mutations at baseline do not increase the risk for a virological failure in HIV-1 subtype B infected patients
Jun 18, 2012PloS one 2012; 7:e37983
Scherrer Alexandra U, Günthard Huldrych F, Bernasconi Enos, Vernazza Pietro, Elzi Luigia, Cavassini Matthias, Calmy Alexandra, Furrer Hansjakob, Cellerai Cristina, Klimkait Thomas, Yerly Sabine, Böni Jürg, von Wyl Viktor, Ledergerber Bruno, Swiss HIV Cohort Study
Incidence of HIV-1 drug resistance among antiretroviral treatment-naive individuals starting modern therapy combinations
von Wyl V, Günthard H, Ledergerber B, Vernazza P, Hirschel B, Furrer H, Cavassini M, Bernasconi E, Battegay M, Klimkait T, Cellerai C, Shah C, Böni J, Yerly S, Swiss HIV Cohort Study. Incidence of HIV-1 drug resistance among antiretroviral treatment-naive individuals starting modern therapy combinations. Clin Infect Dis 2011; 54:131-40.
Nov 4, 2011Incidence of HIV-1 drug resistance among antiretroviral treatment-naive individuals starting modern therapy combinations
Nov 4, 2011Clin Infect Dis 2011; 54:131-40
von Wyl Viktor, Günthard Huldrych F, Ledergerber Bruno, Vernazza Pietro, Hirschel Bernard, Furrer Hansjakob, Cavassini Matthias, Bernasconi Enos, Battegay Manuel, Klimkait Thomas, Cellerai Cristina, Shah Cyril, Böni Jürg, Yerly Sabine, Swiss HIV Cohort Study
Improved virological outcome in White patients infected with HIV-1 non-B subtypes compared to subtype B
Scherrer A, Günthard H, Held L, Bernasconi E, Vernazza P, Elzi L, Cavassini M, Hirschel B, Rauch A, Bürgisser P, Klimkait T, Yerly S, Böni J, von Wyl V, Ledergerber B, Swiss HIV Cohort Study. Improved virological outcome in White patients infected with HIV-1 non-B subtypes compared to subtype B. Clin Infect Dis 2011; 53:1143-52.
Oct 13, 2011Improved virological outcome in White patients infected with HIV-1 non-B subtypes compared to subtype B
Oct 13, 2011Clin Infect Dis 2011; 53:1143-52
Scherrer Alexandra U, Günthard Huldrych F, Held Leonhard, Bernasconi Enos, Vernazza Pietro, Elzi Luigia, Cavassini Matthias, Hirschel Bernard, Rauch Andri, Bürgisser Philippe, Klimkait Thomas, Yerly Sabine, Böni Jürg, von Wyl Viktor, Ledergerber Bruno, Swiss HIV Cohort Study
The role of migration and domestic transmission in the spread of HIV-1 non-B subtypes in Switzerland
von Wyl V, Günthard H, Bonhoeffer S, Ledergerber B, Bernasconi E, Vernazza P, Battegay M, Staehelin C, Cavassini M, Hirschel B, Weber R, Klimkait T, Bürgisser P, Shah C, Böni J, Yerly S, Kouyos R, Swiss HIV Cohort Study. The role of migration and domestic transmission in the spread of HIV-1 non-B subtypes in Switzerland. J Infect Dis 2011; 204:1095-103.
Oct 1, 2011The role of migration and domestic transmission in the spread of HIV-1 non-B subtypes in Switzerland
Oct 1, 2011J Infect Dis 2011; 204:1095-103
von Wyl Viktor, Günthard Huldrych F, Bonhoeffer Sebastian, Ledergerber Bruno, Bernasconi Enos, Vernazza Pietro, Battegay Manuel, Staehelin Cornelia, Cavassini Matthias, Hirschel Bernard, Weber Rainer, Klimkait Thomas, Bürgisser Philippe, Shah Cyril, Böni Jürg, Yerly Sabine, Kouyos Roger D, Swiss HIV Cohort Study
Viral suppression rates in salvage treatment with raltegravir improved with the administration of genotypic partially active or inactive nucleoside/tide reverse transcriptase inhibitors
Scherrer A, Günthard H, Ledergerber B, Bernasconi E, Vernazza P, Battegay M, Cavassini M, Hirschel B, Garzoni C, Bürgisser P, Klimkait T, Yerly S, Böni J, von Wyl V, Swiss HIV Cohort Study (SHCS). Viral suppression rates in salvage treatment with raltegravir improved with the administration of genotypic partially active or inactive nucleoside/tide reverse transcriptase inhibitors. J Acquir Immune Defic Syndr 2011; 57:24-31.
May 1, 2011Viral suppression rates in salvage treatment with raltegravir improved with the administration of genotypic partially active or inactive nucleoside/tide reverse transcriptase inhibitors
May 1, 2011J Acquir Immune Defic Syndr 2011; 57:24-31
Scherrer Alexandra U, Günthard Huldrych F, Ledergerber Bruno, Bernasconi Enos, Vernazza Pietro, Battegay Manuel, Cavassini Matthias, Hirschel Bernard, Garzoni Christian, Bürgisser Philippe, Klimkait Thomas, Yerly Sabine, Böni Jürg, von Wyl Viktor, Swiss HIV Cohort Study (SHCS)